ArriVent BioPharma, Inc.

Q4 2024 13F Holders

Symbol
AVBP
CUSIP
04272N102
Type
Equity
Class
COM
Num filings
81
Total reported value, excl. options
$757 M
Manager Report Date Value ($000) Shares Option Type